DK0588578T4 - Præparat, der indeholder både en oplöselig og en uoplöselig form af et immunogen - Google Patents
Præparat, der indeholder både en oplöselig og en uoplöselig form af et immunogenInfo
- Publication number
- DK0588578T4 DK0588578T4 DK93307185T DK93307185T DK0588578T4 DK 0588578 T4 DK0588578 T4 DK 0588578T4 DK 93307185 T DK93307185 T DK 93307185T DK 93307185 T DK93307185 T DK 93307185T DK 0588578 T4 DK0588578 T4 DK 0588578T4
- Authority
- DK
- Denmark
- Prior art keywords
- immunogen
- antigen
- composition containing
- forms
- soluble
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 abstract 7
- 102000036639 antigens Human genes 0.000 abstract 7
- 108091007433 antigens Proteins 0.000 abstract 7
- 230000028993 immune response Effects 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Radar Systems Or Details Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Jib Cranes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94317392A | 1992-09-14 | 1992-09-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK0588578T3 DK0588578T3 (da) | 2000-03-27 |
| DK0588578T4 true DK0588578T4 (da) | 2005-07-25 |
Family
ID=25479200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93307185T DK0588578T4 (da) | 1992-09-14 | 1993-09-13 | Præparat, der indeholder både en oplöselig og en uoplöselig form af et immunogen |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US5662909A (da) |
| EP (1) | EP0588578B2 (da) |
| JP (1) | JP2512689B2 (da) |
| AT (1) | ATE187338T1 (da) |
| AU (1) | AU677592B2 (da) |
| CA (1) | CA2105629A1 (da) |
| DE (1) | DE69327214T3 (da) |
| DK (1) | DK0588578T4 (da) |
| ES (1) | ES2141750T5 (da) |
| FI (1) | FI110234B (da) |
| GR (1) | GR3032543T3 (da) |
| IL (2) | IL106968A (da) |
| NO (1) | NO313178B1 (da) |
| PT (1) | PT588578E (da) |
| ZA (1) | ZA936629B (da) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6967088B1 (en) * | 1995-03-16 | 2005-11-22 | Allergan, Inc. | Soluble recombinant botulinum toxin proteins |
| ZA964896B (en) * | 1995-06-07 | 1997-01-08 | Connaught Lab | Expression of lipoproteins |
| US6251405B1 (en) * | 1995-06-07 | 2001-06-26 | Connaught Laboratories, Inc. | Immunological combination compositions and methods |
| AU2221600A (en) * | 1998-12-31 | 2000-07-31 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
| US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| AU2487300A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| DK1141315T3 (da) | 1998-12-31 | 2008-05-19 | Novartis Vaccines & Diagnostic | Modificerede HIV Env-polypeptider |
| US20050106137A1 (en) * | 2000-05-05 | 2005-05-19 | Stephen Grimes | Chimeric peptide immunogens |
| PT2301524E (pt) * | 2000-12-27 | 2013-07-10 | Gilead Sciences Inc | Aztreonam inalável sem arginina para tratamento e prevenção de infecções bacterianas pulmonares |
| US20030198621A1 (en) * | 2001-07-05 | 2003-10-23 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof |
| WO2003004620A2 (en) | 2001-07-05 | 2003-01-16 | Chiron, Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| EP1427806A4 (en) * | 2001-08-31 | 2006-04-26 | Chiron Corp | ANTIGENIC HIV-TYPE B POLYPEPTIDE-CODING POLYNUCLEOTIDES, POLYPEPTIDES, AND USES THEREOF |
| US20030170614A1 (en) * | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| US7211258B2 (en) * | 2002-04-10 | 2007-05-01 | Protalex, Inc. | Protein A compositions and methods of use |
| US7425331B2 (en) * | 2002-04-10 | 2008-09-16 | Protalex, Inc. | Protein A methods of use |
| US6814729B2 (en) | 2002-06-27 | 2004-11-09 | Technovision Gmbh | Laser vision correction apparatus and control method |
| WO2011119920A2 (en) | 2010-03-25 | 2011-09-29 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
| DK2691530T3 (da) | 2011-06-10 | 2018-05-22 | Univ Oregon Health & Science | Cmv-glycoproteiner og rekombinante vektorer |
| AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
| US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
| ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
| EP2848937A1 (en) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Methods of identifying novel HIV-1 immunogens |
| EP2873423B1 (en) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| EP3072901A1 (en) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4619828A (en) * | 1982-07-06 | 1986-10-28 | Connaught Laboratories, Inc. | Polysaccharide exotoxoid conjugate vaccines |
| US4496538A (en) * | 1982-07-06 | 1985-01-29 | Connaught Laboratories, Inc. | Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine |
| GB8610983D0 (en) * | 1986-05-06 | 1986-06-11 | Connaught Lab | Enhancement of antigen immunogenicity |
| US4946676A (en) * | 1986-08-27 | 1990-08-07 | De Staat Der Nederlanden | Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide |
| EP0270295A3 (en) * | 1986-12-03 | 1989-08-02 | Connaught Laboratories Limited | Conjugate vaccine |
| DK425789A (da) * | 1988-08-31 | 1990-03-01 | Smithkline Beecham Corp | Vaccinale polypeptider |
| JPH0678245B2 (ja) * | 1989-07-04 | 1994-10-05 | 東興薬品工業株式会社 | 鼻腔内噴霧投与用インフルエンザワクチンゲル製剤 |
| SG47447A1 (en) * | 1990-06-15 | 1998-04-17 | Univ Yale | Compositions and methods for the prevention and diagnosis of lyme disease |
| WO1993008299A1 (en) * | 1991-10-18 | 1993-04-29 | Connaught Laboratories Inc. | Preparation of recombinant borrelia proteins |
-
1993
- 1993-09-07 CA CA002105629A patent/CA2105629A1/en not_active Abandoned
- 1993-09-08 AU AU46226/93A patent/AU677592B2/en not_active Ceased
- 1993-09-08 ZA ZA936629A patent/ZA936629B/xx unknown
- 1993-09-10 IL IL10696893A patent/IL106968A/en not_active IP Right Cessation
- 1993-09-13 NO NO19933261A patent/NO313178B1/no unknown
- 1993-09-13 DK DK93307185T patent/DK0588578T4/da active
- 1993-09-13 DE DE69327214T patent/DE69327214T3/de not_active Expired - Fee Related
- 1993-09-13 ES ES93307185T patent/ES2141750T5/es not_active Expired - Lifetime
- 1993-09-13 EP EP93307185A patent/EP0588578B2/en not_active Expired - Lifetime
- 1993-09-13 PT PT93307185T patent/PT588578E/pt unknown
- 1993-09-13 AT AT93307185T patent/ATE187338T1/de not_active IP Right Cessation
- 1993-09-14 JP JP5229041A patent/JP2512689B2/ja not_active Expired - Lifetime
- 1993-09-14 FI FI934013A patent/FI110234B/fi not_active IP Right Cessation
-
1995
- 1995-02-08 US US08/385,587 patent/US5662909A/en not_active Expired - Fee Related
- 1995-06-06 US US08/470,278 patent/US5837264A/en not_active Expired - Lifetime
-
1997
- 1997-02-18 US US08/801,152 patent/US5853736A/en not_active Expired - Fee Related
-
1998
- 1998-11-17 US US09/193,682 patent/US6024963A/en not_active Expired - Lifetime
-
1999
- 1999-05-23 IL IL13007599A patent/IL130075A0/xx unknown
-
2000
- 2000-02-02 GR GR20000400239T patent/GR3032543T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0588578B2 (en) | 2005-04-13 |
| AU677592B2 (en) | 1997-05-01 |
| AU4622693A (en) | 1994-03-24 |
| ZA936629B (en) | 1994-03-30 |
| NO313178B1 (no) | 2002-08-26 |
| FI934013A (fi) | 1994-03-15 |
| IL106968A0 (en) | 1993-12-28 |
| NO933261L (no) | 1994-03-15 |
| US5837264A (en) | 1998-11-17 |
| NO933261D0 (no) | 1993-09-13 |
| JPH06192125A (ja) | 1994-07-12 |
| DE69327214T2 (de) | 2000-09-07 |
| FI934013A0 (fi) | 1993-09-14 |
| DE69327214D1 (de) | 2000-01-13 |
| IL106968A (en) | 1999-10-28 |
| EP0588578B1 (en) | 1999-12-08 |
| ES2141750T3 (es) | 2000-04-01 |
| ES2141750T5 (es) | 2005-12-01 |
| GR3032543T3 (en) | 2000-05-31 |
| PT588578E (pt) | 2000-05-31 |
| EP0588578A1 (en) | 1994-03-23 |
| US5662909A (en) | 1997-09-02 |
| FI110234B (fi) | 2002-12-31 |
| DE69327214T3 (de) | 2005-12-01 |
| CA2105629A1 (en) | 1994-03-15 |
| ATE187338T1 (de) | 1999-12-15 |
| JP2512689B2 (ja) | 1996-07-03 |
| US6024963A (en) | 2000-02-15 |
| IL130075A0 (en) | 2000-02-29 |
| DK0588578T3 (da) | 2000-03-27 |
| US5853736A (en) | 1998-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0588578T4 (da) | Præparat, der indeholder både en oplöselig og en uoplöselig form af et immunogen | |
| FI943171A (fi) | Ureaasipohjainen rokote Helicobacter-infektiota vastaan | |
| DK0642355T3 (da) | Kombinerede vacciner, der omfatter hepatitis B-overfladeantigen og andre antigener | |
| SE8604007D0 (sv) | Vaccin och immunoanalyser for forvervat immunbristsyndrom (aids) | |
| ES2139810T3 (es) | Retrovirus recombinantes. | |
| IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
| WO1991002805A3 (en) | Recombinant retroviruses delivering vector constructs to target cells | |
| DK1637593T3 (da) | Fremgangsmåde til inaktivering af lipidomhyllede vira | |
| ES2091777T3 (es) | Procedimiento para preparar un ensayo inmunologico de transferencia western. | |
| ES2103828T3 (es) | Particulas viricas ensambladas y su uso en una vacuna contra una enfermedad rotavirica. | |
| DK0838222T3 (da) | Vaccinesammensætninger, der omfatter inaktiverede immunogener og levende kyllingeanæmi-virus (CAV) | |
| DK545889A (da) | Anti-human-immundefektvirus-praeparat | |
| DK373489D0 (da) | Rekombinante hybrid-partikler med morphologiske egenskaber svarende til antigenet hbsag og omfattende en immunogen sekvens, der inducerer neutraliserende antistoffer rettet mod hiv-retrovirus eller som kan genkendes af saadanne antistoffer, samt vaccine paa basis af saadanne partikler | |
| SE9604322D0 (sv) | Bacterial antigens and vaccine compositions II | |
| BR9910157A (pt) | Composição | |
| ATE385809T1 (de) | Saponin-zusammensetzungen und deren verwendung | |
| DK0563288T3 (da) | Immunopotentiering af vacciner, navnlig svinepleuropneumoniavacciner | |
| ES2056780T1 (es) | Un procedimiento para el aislamiento de virus de hav. | |
| ES2031922T3 (es) | Composiciones terapeuticas estables a base de aceite vegetal hidrofobo y su procedimiento de preparacion. | |
| GR1000098B (el) | Παραγωγα διοξαζοκινης, παρασκευη των και συνθεσεις που τα περιεχουν. | |
| DK0542895T3 (da) | Krydsreaktiv influenza A immunisering | |
| MX24401A (es) | (1)benzopirano(4,3-c)pirazoles y (1)benzotiopirano(1)benzopirano(4,3-c)pirazoles y (1)benzotiopirano(4,3-c)pirazoles, procedimiento para su preparacio(4,3-c)pirazoles, procedimiento para su preparacion y composiciones farmaceuticas que los contienen n y composiciones farmaceuticas que los contienen | |
| IT8247648A0 (it) | Composizione copolimerica antigengi vite e procedimento di preparazione |